Dissemination of carbapenem and colistin resistance in Gram-negative bacteria: the emerging role of novel β-lactam/β-lactamase inhibitors for managing a global dilemma
Advances in Medical, Pharmaceutical and Dental Research · 2025
DOI: 10.21622/1790 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Medical, Pharmaceutical and Dental Research, 2025. Verfasst von Mohamed T. Ateeba und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Ateeba, M. T., El-Kholy, M. A., Alseqely, M., Edward, E. A., & El-Nakeeb, M. (2025). Dissemination of carbapenem and colistin resistance in Gram-negative bacteria: the emerging role of novel β-lactam/β-lactamase inhibitors for managing a global dilemma. Advances in Medical, Pharmaceutical and Dental Research. https://doi.org/10.21622/1790
Vancouver
Ateeba MT, El-Kholy MA, Alseqely M, Edward EA, El-Nakeeb M. Dissemination of carbapenem and colistin resistance in Gram-negative bacteria: the emerging role of novel β-lactam/β-lactamase inhibitors for managing a global dilemma. Advances in Medical, Pharmaceutical and Dental Research. 2025. doi:10.21622/1790
BibTeX
@article{Ateeba2025,
author = {Ateeba, Mohamed T. and El-Kholy, Mohammed A. and Alseqely, Mustafa and Edward, Eva A. and El-Nakeeb, Mostafa},
title = {Dissemination of carbapenem and colistin resistance in Gram-negative bacteria: the emerging role of novel β-lactam/β-lactamase inhibitors for managing a global dilemma},
journal = {Advances in Medical, Pharmaceutical and Dental Research},
year = {2025},
doi = {10.21622/1790}
}
EUVIMED